Display options
Share it on

Front Immunol. 2021 Sep 01;12:727952. doi: 10.3389/fimmu.2021.727952. eCollection 2021.

Optimal Isolation Protocols for Examining and Interrogating Mononuclear Phagocytes From Human Intestinal Tissue.

Frontiers in immunology

Chloe M Doyle, Erica E Vine, Kirstie M Bertram, Heeva Baharlou, Jake W Rhodes, Suat Dervish, Martijn P Gosselink, Angelina Di Re, Geoffrey P Collins, Faizur Reza, James W T Toh, Nimalan Pathma-Nathan, Golo Ahlenstiel, Grahame Ctercteko, Anthony L Cunningham, Andrew N Harman, Scott N Byrne

Affiliations

  1. Centre for Immunology and Allergy Research, The Westmead Institute for Medical Research, Westmead, NSW, Australia.
  2. Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, NSW, Australia.
  3. School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia.
  4. Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia.
  5. Westmead Cytometry, The Westmead Institute for Medical Research, Westmead, NSW, Australia.
  6. Department of Colorectal Surgery, Westmead Hospital, Westmead, NSW, Australia.
  7. Storr Liver Centre, The Westmead Institute for Medical Research, Westmead, NSW, Australia.
  8. Blacktown Clinical School, Western Sydney University, Blacktown, NSW, Australia.
  9. Blacktown Hospital, Western Sydney Local Area Health District (WSLHD), Blacktown, NSW, Australia.

PMID: 34566985 PMCID: PMC8462295 DOI: 10.3389/fimmu.2021.727952

Abstract

The human intestine contains numerous mononuclear phagocytes (MNP), including subsets of conventional dendritic cells (cDC), macrophages (Mf) and monocytes, each playing their own unique role within the intestinal immune system and homeostasis. The ability to isolate and interrogate MNPs from fresh human tissue is crucial if we are to understand the role of these cells in homeostasis, disease settings and immunotherapies. However, liberating these cells from tissue is problematic as many of the key surface identification markers they express are susceptible to enzymatic cleavage and they are highly susceptible to cell death. In addition, the extraction process triggers immunological activation/maturation which alters their functional phenotype. Identifying the evolving, complex and highly heterogenous repertoire of MNPs by flow cytometry therefore requires careful selection of digestive enzyme blends that liberate viable cells and preserve recognition epitopes involving careful selection of antibody clones to enable analysis and sorting for functional assays. Here we describe a method for the anatomical separation of mucosa and submucosa as well as isolating lymphoid follicles from human jejunum, ileum and colon. We also describe in detail the optimised enzyme digestion methods needed to acquire functionally immature and biologically functional intestinal MNPs. A comprehensive list of screened antibody clones is also presented which allows for the development of high parameter flow cytometry panels to discriminate all currently identified human tissue MNP subsets including pDCs, cDC1, cDC2 (langerin

Copyright © 2021 Doyle, Vine, Bertram, Baharlou, Rhodes, Dervish, Gosselink, Di Re, Collins, Reza, Toh, Pathma-Nathan, Ahlenstiel, Ctercteko, Cunningham, Harman and Byrne.

Keywords: dendritic cells (DC); enzymatic digestion; flow cytometry; human tissue; intestine; macrophage – cell; mononuclear phagocyte cells (MNP)

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. J Exp Med. 2015 May 4;212(5):743-57 - PubMed
  2. J Leukoc Biol. 2017 Jun;101(6):1393-1403 - PubMed
  3. Immunity. 2019 Sep 17;51(3):573-589.e8 - PubMed
  4. Semin Cell Dev Biol. 2015 May;41:59-69 - PubMed
  5. J Exp Med. 2009 Feb 16;206(2):371-85 - PubMed
  6. J Dermatol Sci. 2015 Feb;77(2):85-92 - PubMed
  7. J Exp Med. 2010 Jun 7;207(6):1273-81 - PubMed
  8. Sci Rep. 2017 Sep 29;7(1):12409 - PubMed
  9. Nat Immunol. 2014 Jan;15(1):98-108 - PubMed
  10. Nat Rev Immunol. 2011 Oct 25;11(11):788-98 - PubMed
  11. Immunity. 2020 Aug 18;53(2):335-352.e8 - PubMed
  12. Nat Commun. 2021 Apr 12;12(1):2147 - PubMed
  13. J Exp Med. 2019 Jan 7;216(1):20-40 - PubMed
  14. Immunity. 2020 Mar 17;52(3):557-570.e6 - PubMed
  15. J Immunol. 2014 Sep 1;193(5):2554-64 - PubMed
  16. Science. 2017 Apr 21;356(6335): - PubMed
  17. Front Immunol. 2020 Mar 18;11:410 - PubMed
  18. Mucosal Immunol. 2018 Sep;11(5):1512-1523 - PubMed
  19. Nat Commun. 2019 Jun 21;10(1):2759 - PubMed
  20. Immunity. 2012 Jul 27;37(1):60-73 - PubMed
  21. J Immunol. 2006 Nov 15;177(10):7103-13 - PubMed
  22. Nat Protoc. 2021 Apr;16(4):2051-2067 - PubMed
  23. Annu Rev Immunol. 2000;18:767-811 - PubMed
  24. J Immunol. 2013 Jan 1;190(1):66-79 - PubMed
  25. J Leukoc Biol. 2015 Apr;97(4):627-34 - PubMed
  26. J Immunol Methods. 2016 May;432:35-49 - PubMed
  27. Immunology. 2018 May;154(1):3-20 - PubMed
  28. Immunity. 2020 Aug 18;53(2):353-370.e8 - PubMed
  29. Front Immunol. 2018 Dec 06;9:2883 - PubMed
  30. Nat Commun. 2021 May 17;12(1):2890 - PubMed
  31. Curr Protoc Immunol. 2001 May;Chapter 3:Unit 3.19 - PubMed
  32. J Exp Med. 2012 May 7;209(5):935-45 - PubMed
  33. J Exp Med. 2018 Feb 5;215(2):441-458 - PubMed

Publication Types